INmune Bio Inc. (INMB)

NASDAQ: INMB · Real-Time Price · USD

1.340

-0.010 (-0.74%)

Feb 19, 2026, 2:08 PM EST - Market open

INmune Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	36	104	203	114	182	232
Market Cap Growth	-83.54%	-48.97%	78.35%	-37.48%	-21.41%	270.69%
Enterprise Value	9	73	175	72	112	207
Last Close Price	1.35	4.67	11.26	6.34	10.20	17.22
PS Ratio	717.80	7396.10	1309.19	304.22	1005.53	21052.15
PB Ratio	1.41	3.23	5.32	1.89	2.27	5.98
P/TBV Ratio	1.41	6.65	9.74	2.61	2.86	10.41
EV/Sales Ratio	184.72	5207.60	1127.89	191.85	619.14	18856.25
Debt / Equity Ratio	0.04	0.01	0.27	0.26	0.19	0.00
Net Debt / Equity Ratio	-1.05	-0.64	-0.67	-0.61	-0.74	-0.56
Asset Turnover	0.00	0	0.00	0.00	0.00	0
Quick Ratio	4.11	3.09	2.07	5.55	18.43	13.38
Current Ratio	4.17	3.14	2.16	5.92	18.95	13.51
Return on Equity (ROE)	-155.77%	-119.83%	-61.09%	-38.91%	-51.00%	-38.80%
Return on Assets (ROA)	-50.59%	-55.19%	-26.78%	-17.85%	-25.92%	-23.47%
Return on Capital Employed (ROCE)	-134.10%	-131.80%	-77.20%	-36.60%	-30.50%	-31.50%
Earnings Yield	-139.00%	-40.64%	-14.79%	-23.99%	-16.67%	-5.22%
Buyback Yield / Dilution	-25.30%	-10.92%	-0.30%	-11.14%	-34.55%	-16.70%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q